Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Drug Alcohol Depend. 2022 Dec 20;243:109741. doi: 10.1016/j.drugalcdep.2022.109741

Table 2.

Model summary for chemsex associated substances use among MSM

Substance Study Substance use Total sample size Prevalence Pooled effect (95%CI) τ Notes
Cocaine (Ko et al., 2012) 12 1645 0.01 (0.00, 0.01) 0.01 (0.00, 0.03) 0.01 In the past 6 months
(Lim et al., 2015) 15 1235 0.01 (0.01, 0.02) In the past 6 months
(Sapsirisavat et al., 2016) 3 499 0.01 (0.00, 0.01) Categorised to rare/regular
(Sze et al., 2020) 29 569 0.05 (0.03, 0.07) In the past 6 months
(Z. Wang et al., 2020) 0 88 0.01 (0.00, 0.01) In the past year
(Yang et al., 2016) 1 205 0.00 (0.00, 0.01) MSMLHIV

GHB/GBL (Ko et al., 2012) 33 1645 0.02 (0.01, 0.03) 0.15 (0.03, 0.27) 0.15 In the past 6 months
(Lim et al., 2015) 34 1235 0.03 (0.02,0.04) In the past 6 months
(Sze et al., 2020) 200 569 0.35 (0.31, 0.39) In the past 6 months
(Tan et al., 2021) 27 570 0.05 (0.03, 0.06) -
(Z. Wang et al., 2020) 29 88 0.33 (0.23, 0.43) in the past year
(Wu et al., 2019) 10 79 0.13 (0.05, 0.20) MSMLHIV

Ketamine (Ko et al., 2012) 204 1645 0.12 (0.11, 0.14) 0.08 (0.04,0.12) 0.05 In the past 6 months
(Lim et al., 2015) 76 1235 0.06 (0.05, 0.07) In the past 6 months
(Nemoto et al., 2012) 22 112 0.20 (0.12, 0.27) Kathoey
(Sze et al., 2020) 63 569 0.11 (0.08, 0.14) In the past 6 months
(N. T. Vu et al., 2017) 8 622 0.01 (0.00, 0.02) -
(Z. Wang et al., 2020) 2 88 0.02 (−0.01, 0.05) In the past year
(Wu et al., 2019) 6 79 0.08 (0.02, 0.13) MSMLHIV
(Yang et al., 2016) 12 205 0.06 (0.03, 0.09) MSMLHIV

Methamphet amine (Duong et al., 2018) 15 45 0.33 (0.20, 0.47) 0.16 (0.09, 0.22) 0.13 -
(Han et al., 2020) 16 48 0.33 (0.20, 0.47) MSMLHIV
(Hidaka et al., 2014) 211 5731 0.04 (0.03, 0.04) -
(Ko et al., 2012) 25 1645 0.02 (0.01, 0.02) In the past 6 months
(Lim et al., 2015) 87 1235 0.07 (0.06, 0.08) In the past 6 months
(Nishijima et al., 2013) 57 973 0.06 (0.04, 0.07) History of illicit drug use among HIV positive samples
(Piyaraj et al., 2018) 128 1372 0.09 (0.08, 0.11) -
(Sapsirisavat et al., 2016) 18 499 0.04 (0.02, 0.05) Categorised to rare/regular
(Sze et al., 2020) 222 569 0.39 (0.35, 0.43) In the past 6 months
(Tan et al., 2021) 27 570 0.05 (0.03, 0.06) -
(N. T. Vu et al., 2017; N. T. T. Vu et al., 2017) 89 622 0.14 (0.12, 0.17) -
(Z. Wang et al., 2020) 32 88 0.36 (0.26, 0.46) In the past year
(Wansom et al., 2020) 98 563 0.17 (0.14, 0.21) MSMLHIV
(Wu et al., 2019) 21 79 0.27 (0.17, 0,36) MSMLHIV
(Yang et al., 2016) 26 205 0.13 (0.08, 0.17) MSMLHIV

Notes: - refers to information not applicable. 95% CI = 95% confident interval. MSMLHIV = men have sex with men living with HIV. The scale on the effects is prevalence.